Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
50
PGNY Quote, Financials, Valuation and Earnings
Last price:
$23.02
Seasonality move
:
-4.47%
Day range:
$22.60 - $23.34
52-week range:
$13.39 - $30.42
Dividend yield:
0%
P/E ratio:
40.39x
P/S ratio:
1.78x
P/B ratio:
4.22x
Volume:
794K
Avg. volume:
1.1M
1-year change:
-23.27%
Market cap:
$2B
Revenue:
$1.2B
EPS (TTM):
$0.57
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $344.9M | $500.6M | $786.9M | $1.1B | $1.2B | |
| Revenue Growth (YoY) | 50.15% | 45.17% | 57.19% | 38.34% | 7.22% | |
| Cost of Revenues | $274.8M | $388.5M | $619.6M | $849.8M | $913.9M | |
| Gross Profit | $70.1M | $112.1M | $167.3M | $238.8M | $253.4M | |
| Gross Profit Margin | 20.32% | 22.4% | 21.26% | 21.94% | 21.71% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $61.7M | $79.8M | $144M | $176.6M | $185.9M | |
| Other Inc / (Exp) | $210K | -$366K | $286K | $5.2M | -- | |
| Operating Expenses | $61.7M | $79.8M | $144M | $176.6M | $185.9M | |
| Operating Income | $8.3M | $32.3M | $23.3M | $62.2M | $67.5M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $8.7M | $32.4M | $24.4M | $70.7M | $83.2M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$37.8M | -$33.3M | -$5.9M | $8.7M | $28.9M | |
| Net Income to Company | $46.5M | $65.8M | $30.4M | $62M | $54.3M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $46.5M | $65.8M | $30.4M | $62M | $54.3M | |
| Basic EPS (Cont. Ops) | $0.54 | $0.74 | $0.33 | $0.65 | $0.59 | |
| Diluted EPS (Cont. Ops) | $0.47 | $0.66 | $0.30 | $0.62 | $0.57 | |
| Weighted Average Basic Share | $85.7M | $89.1M | $92.2M | $95M | $91.5M | |
| Weighted Average Diluted Share | $99.1M | $100.4M | $100M | $100.7M | $95.4M | |
| EBITDA | $10.3M | $33.6M | $24.9M | $64.5M | $70.6M | |
| EBIT | $8.3M | $32.3M | $23.3M | $62.2M | $67.5M | |
| Revenue (Reported) | $344.9M | $500.6M | $786.9M | $1.1B | $1.2B | |
| Operating Income (Reported) | $8.3M | $32.3M | $23.3M | $62.2M | $67.5M | |
| Operating Income (Adjusted) | $8.3M | $32.3M | $23.3M | $62.2M | $67.5M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $122.1M | $172.2M | $258.4M | $278.1M | $324M | |
| Revenue Growth (YoY) | 50.74% | 41.01% | 50.04% | 7.62% | 16.53% | |
| Cost of Revenues | $93.2M | $139.3M | $199.8M | $215.7M | $248.2M | |
| Gross Profit | $28.9M | $32.9M | $58.6M | $62.4M | $75.8M | |
| Gross Profit Margin | 23.67% | 19.13% | 22.69% | 22.44% | 23.39% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $17.1M | $33M | $43.6M | $43.9M | $51.6M | |
| Other Inc / (Exp) | $7K | -$96K | $498K | -- | -- | |
| Operating Expenses | $17.1M | $33M | $43.6M | $43.9M | $51.6M | |
| Operating Income | $11.8M | -$58K | $15M | $18.5M | $24.2M | |
| Net Interest Expenses | $18K | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $11.8M | -$142K | $16.3M | $22.5M | $26.5M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$3.4M | -$5.1M | -$1.3M | $5.6M | $11.5M | |
| Net Income to Company | $15.2M | $5M | $17.7M | $16.9M | $15.1M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $15.2M | $5M | $17.7M | $16.9M | $15.1M | |
| Basic EPS (Cont. Ops) | $0.17 | $0.05 | $0.19 | $0.18 | $0.18 | |
| Diluted EPS (Cont. Ops) | $0.15 | $0.05 | $0.18 | $0.17 | $0.17 | |
| Weighted Average Basic Share | $87.4M | $91.4M | $93.8M | $96.5M | $85.5M | |
| Weighted Average Diluted Share | $100.1M | $99.9M | $100.2M | $101.1M | $89.3M | |
| EBITDA | $12.2M | $306K | $15.6M | $19.2M | $25.3M | |
| EBIT | $11.8M | -$58K | $15M | $18.5M | $24.2M | |
| Revenue (Reported) | $122.1M | $172.2M | $258.4M | $278.1M | $324M | |
| Operating Income (Reported) | $11.8M | -$58K | $15M | $18.5M | $24.2M | |
| Operating Income (Adjusted) | $11.8M | -$58K | $15M | $18.5M | $24.2M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $386M | $550.7M | $873.1M | $1.1B | $1.2B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $303.6M | $434.5M | $680.1M | $865.7M | $946.4M | |
| Gross Profit | $82.4M | $116.2M | $193M | $242.6M | $266.8M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $65.6M | $95.7M | $154.6M | $176.9M | $193.7M | |
| Other Inc / (Exp) | $53K | -$469K | $605K | $1.3M | $3.6M | |
| Operating Expenses | $65.6M | $95.7M | $154.6M | $176.9M | $193.7M | |
| Operating Income | $16.7M | $20.5M | $38.4M | $65.7M | $73.1M | |
| Net Interest Expenses | $47K | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $16.7M | $20.5M | $40.9M | $76.9M | $87.2M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$41.3M | -$35.1M | -$2.2M | $15.6M | $34.7M | |
| Net Income to Company | $58M | $55.6M | $43.1M | $61.3M | $52.5M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $58M | $55.6M | $43.1M | $61.3M | $52.5M | |
| Basic EPS (Cont. Ops) | $0.67 | $0.62 | $0.47 | $0.65 | $0.60 | |
| Diluted EPS (Cont. Ops) | $0.58 | $0.56 | $0.43 | $0.61 | $0.57 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $18.5M | $21.7M | $40.2M | $68.2M | $76.7M | |
| EBIT | $16.7M | $20.5M | $38.4M | $65.7M | $73.1M | |
| Revenue (Reported) | $386M | $550.7M | $873.1M | $1.1B | $1.2B | |
| Operating Income (Reported) | $16.7M | $20.5M | $38.4M | $65.7M | $73.1M | |
| Operating Income (Adjusted) | $16.7M | $20.5M | $38.4M | $65.7M | $73.1M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $122.1M | $172.2M | $258.4M | $278.1M | $324M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $93.2M | $139.3M | $199.8M | $215.7M | $248.2M | |
| Gross Profit | $28.9M | $32.9M | $58.6M | $62.4M | $75.8M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $17.1M | $33M | $43.6M | $43.9M | $51.6M | |
| Other Inc / (Exp) | $7K | -$96K | $498K | -- | -- | |
| Operating Expenses | $17.1M | $33M | $43.6M | $43.9M | $51.6M | |
| Operating Income | $11.8M | -$58K | $15M | $18.5M | $24.2M | |
| Net Interest Expenses | $18K | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $11.8M | -$142K | $16.3M | $22.5M | $26.5M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$3.4M | -$5.1M | -$1.3M | $5.6M | $11.5M | |
| Net Income to Company | $15.2M | $5M | $17.7M | $16.9M | $15.1M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $15.2M | $5M | $17.7M | $16.9M | $15.1M | |
| Basic EPS (Cont. Ops) | $0.17 | $0.05 | $0.19 | $0.18 | $0.18 | |
| Diluted EPS (Cont. Ops) | $0.15 | $0.05 | $0.18 | $0.17 | $0.17 | |
| Weighted Average Basic Share | $87.4M | $91.4M | $93.8M | $96.5M | $85.5M | |
| Weighted Average Diluted Share | $100.1M | $99.9M | $100.2M | $101.1M | $89.3M | |
| EBITDA | $12.2M | $306K | $15.6M | $19.2M | $25.3M | |
| EBIT | $11.8M | -$58K | $15M | $18.5M | $24.2M | |
| Revenue (Reported) | $122.1M | $172.2M | $258.4M | $278.1M | $324M | |
| Operating Income (Reported) | $11.8M | -$58K | $15M | $18.5M | $24.2M | |
| Operating Income (Adjusted) | $11.8M | -$58K | $15M | $18.5M | $24.2M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $70.3M | $91.4M | $120.1M | $97.3M | $162.3M | |
| Short Term Investments | $39M | $28M | $69.2M | $273.8M | $65.6M | |
| Accounts Receivable, Net | $75.7M | $134.6M | $240.1M | $241.9M | $235.3M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $5.3M | $4.6M | $4.5M | $27.5M | $9.4M | |
| Total Current Assets | $190.2M | $258.5M | $433.9M | $640.4M | $472.7M | |
| Property Plant And Equipment | $12.1M | $12.8M | $15.3M | $27.8M | $29.6M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $11.9M | $11.9M | $11.9M | $11.9M | $15.5M | |
| Other Intangibles | $1.2M | $599K | $99K | -- | $1.3M | |
| Other Long-Term Assets | $573K | $2.9M | $4M | $3.4M | $3M | |
| Total Assets | $253.9M | $358.1M | $543M | $756.6M | $607.1M | |
| Accounts Payable | $43.5M | $61.4M | $109.3M | $125.4M | $95.1M | |
| Accrued Expenses | $2.6M | $3.9M | $9M | $15M | $18.7M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $1.2M | $1.2M | $1.2M | $2.1M | $2.9M | |
| Other Current Liabilities | $2.6M | $2.2M | $1.2M | $1.2M | $5.3M | |
| Total Current Liabilities | $77.8M | $98.8M | $159.5M | $186M | $168.6M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $87M | $106.2M | $166M | $203.2M | $185M | |
| Common Stock | $9K | $9K | $9K | $9K | $9K | |
| Other Common Equity Adj | $1K | -$93K | $501K | $2.8M | $39K | |
| Common Equity | $166.9M | $251.8M | $377M | $553.4M | $422.1M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $166.9M | $251.8M | $377M | $553.4M | $422.1M | |
| Total Liabilities and Equity | $253.9M | $358.1M | $543M | $756.6M | $607.1M | |
| Cash and Short Terms | $109.3M | $119.4M | $189.3M | $371.1M | $228M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $29.8M | $38.8M | $155.3M | $115M | $109.2M | |
| Short Term Investments | $77.1M | $66.9M | $52.6M | $256.9M | $146.9M | |
| Accounts Receivable, Net | $116.7M | $198.1M | $313.2M | $297.2M | $299.7M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $4.2M | $5.2M | $5.9M | $12.5M | $11.8M | |
| Total Current Assets | $227.8M | $309M | $527.1M | $681.5M | $567.7M | |
| Property Plant And Equipment | $12M | $13.4M | $27.8M | $27.4M | $42.7M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $11.9M | $11.9M | $11.9M | $11.9M | $19.7M | |
| Other Intangibles | $973K | $473K | -- | -- | $6.8M | |
| Other Long-Term Assets | $556K | $4.3M | $3.8M | $3.2M | $8.6M | |
| Total Assets | $294.6M | $415.5M | $649.7M | $794.3M | $730.3M | |
| Accounts Payable | $57.3M | $84.7M | $145.6M | $130.2M | $145.7M | |
| Accrued Expenses | $43.7M | $44M | $61.2M | $75.7M | $91.4M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $101M | $128.7M | $206.9M | $205.9M | $237.1M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $110M | $135.9M | $225.3M | $222.7M | $263.1M | |
| Common Stock | $9K | $9K | $9K | $9K | $9K | |
| Other Common Equity Adj | -$50K | -$11K | $724K | $2.8M | $110K | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $184.6M | $279.6M | $424.4M | $571.6M | $467.2M | |
| Total Liabilities and Equity | $294.6M | $415.5M | $649.7M | $794.3M | $730.3M | |
| Cash and Short Terms | $106.9M | $105.7M | $207.9M | $371.8M | $256.1M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $46.5M | $65.8M | $30.4M | $62M | $54.3M | |
| Depreciation & Amoritzation | $1.9M | $1.3M | $1.6M | $2.3M | $3.2M | |
| Stock-Based Compensation | $12.8M | $33.7M | $100.7M | $122.6M | $128.1M | |
| Change in Accounts Receivable | -$35.3M | -$68.7M | -$119.3M | -$21.7M | -$9.9M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $36.2M | $26M | $80.4M | $188.8M | $179.1M | |
| Capital Expenditures | $1M | $2.1M | $3.2M | $3.6M | $5.4M | |
| Cash Acquisitions | -- | -- | -- | -- | -$5.3M | |
| Cash From Investing | -$40M | $8.8M | -$43.9M | -$200.5M | $195.8M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -$300.3M | |
| Other Financing Activities | -$9.8M | -$18M | -$12.1M | -$17.2M | -$12M | |
| Cash From Financing | -$6.2M | -$13.7M | -$7.9M | -$11.1M | -$309.9M | |
| Beginning Cash (CF) | $80.4M | $70.3M | $91.4M | $120.1M | $97.3M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$10.1M | $21.1M | $28.7M | -$22.8M | $65M | |
| Ending Cash (CF) | $70.3M | $91.4M | $120.1M | $97.3M | $162.3M | |
| Levered Free Cash Flow | $35.2M | $23.9M | $77.2M | $185.2M | $173.7M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $15.2M | $5M | $17.7M | $16.9M | $15.1M | |
| Depreciation & Amoritzation | $422K | $364K | $541K | $716K | $1.1M | |
| Stock-Based Compensation | $5M | $24.5M | $30.8M | $31.1M | $32.5M | |
| Change in Accounts Receivable | -$43.5M | -$65.8M | -$78.4M | -$60.1M | -$69.7M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $532K | -$11.3M | $21M | $25.7M | $49.8M | |
| Capital Expenditures | $369K | $790K | $1.3M | $850K | $2.8M | |
| Cash Acquisitions | -- | -- | -- | -- | -$9.3M | |
| Cash From Investing | -$38.5M | -$39.6M | $16.1M | $19.3M | -$94.6M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -$23.8M | -- | |
| Other Financing Activities | -$3.5M | -$3M | -$3.8M | -$5M | -$3.6M | |
| Cash From Financing | -$2.5M | -$1.8M | -$1.8M | -$27.4M | -$3.3M | |
| Beginning Cash (CF) | $70.3M | $91.4M | $120.1M | $97.3M | $162.3M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -$2K | $15K | |
| Additions / Reductions | -$40.5M | -$52.6M | $35.2M | $17.7M | -$48.1M | |
| Ending Cash (CF) | $29.8M | $38.8M | $155.3M | $115M | $114.2M | |
| Levered Free Cash Flow | $163K | -$12.1M | $19.7M | $24.9M | $47M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $58M | $55.6M | $43.1M | $61.3M | $52.5M | |
| Depreciation & Amoritzation | $1.8M | $1.2M | $1.8M | $2.5M | $3.6M | |
| Stock-Based Compensation | $15.8M | $53.2M | $107.1M | $122.9M | $129.6M | |
| Change in Accounts Receivable | -$58.8M | -$91M | -$131.9M | -$3.4M | -$19.5M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $24.6M | $14.2M | $112.6M | $193.6M | $203.2M | |
| Capital Expenditures | $713K | $2.6M | $3.7M | $3.2M | $7.4M | |
| Cash Acquisitions | -- | -- | -- | -- | -$14.6M | |
| Cash From Investing | -$77.9M | $7.7M | $11.8M | -$197.3M | $81.8M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -$23.8M | -$276.5M | |
| Other Financing Activities | -$12.6M | -$17.4M | -$12.9M | -$18.3M | -$10.6M | |
| Cash From Financing | -$8.6M | -$13M | -$7.9M | -$36.6M | -$285.8M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$61.8M | $9M | $116.5M | -$40.4M | -$738K | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $23.9M | $11.7M | $108.9M | $190.3M | $195.8M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $15.2M | $5M | $17.7M | $16.9M | $15.1M | |
| Depreciation & Amoritzation | $422K | $364K | $541K | $716K | $1.1M | |
| Stock-Based Compensation | $5M | $24.5M | $30.8M | $31.1M | $32.5M | |
| Change in Accounts Receivable | -$43.5M | -$65.8M | -$78.4M | -$60.1M | -$69.7M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $532K | -$11.3M | $21M | $25.7M | $49.8M | |
| Capital Expenditures | $369K | $790K | $1.3M | $850K | $2.8M | |
| Cash Acquisitions | -- | -- | -- | -- | -$9.3M | |
| Cash From Investing | -$38.5M | -$39.6M | $16.1M | $19.3M | -$94.6M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -$23.8M | -- | |
| Other Financing Activities | -$3.5M | -$3M | -$3.8M | -$5M | -$3.6M | |
| Cash From Financing | -$2.5M | -$1.8M | -$1.8M | -$27.4M | -$3.3M | |
| Beginning Cash (CF) | $70.3M | $91.4M | $120.1M | $97.3M | $162.3M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -$2K | $15K | |
| Additions / Reductions | -$40.5M | -$52.6M | $35.2M | $17.7M | -$48.1M | |
| Ending Cash (CF) | $29.8M | $38.8M | $155.3M | $115M | $114.2M | |
| Levered Free Cash Flow | $163K | -$12.1M | $19.7M | $24.9M | $47M | |
Get PGNY Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
PGNY
Sector
P/E ratio
40.39x
23.88x
PEG ratio
3.42x
0.00x
P/B ratio
4.22x
1.80x
Price / LTM sales
1.78x
1.65x
Growth Metrics
PGNY
Sector
Revenue growth
16.53%
4.06%
Earnings growth
--
7.46%
Revenue (5-year growth)
38.42%
8.01%
Earnings forecast
$0.42
-$0.20
Profitability
PGNY
Sector
Profitability FY 2024
$253.4M
$47.5M
Return on invested capital
11.16%
-16.26%
Return on assets
7.52%
-13.27%
Return on equity
11.16%
-18.61%
Earnings Date
Last Earnings Date
May
8
Next Earnings Date
Aug
7
Estimated Next Earnings Date
Aug
7
Balance Sheet
PGNY
Sector
Total cash
$256.1M
$35.5M
Short term investments
$65.6M
$29.7M
Total assets
$607.1M
$106.9M
Long term debt
--
$7.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 18
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
